Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Respiratory and Critical Care Medicine|January 25, 2005
Characteristics of physical activities in daily life in chronic obstructive pulmonary diseaseFabio Pitta, Thierry Troosters, Martijn A Spruit, et al.
Archives of Physical Medicine and Rehabilitation|September 27, 2005
Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary diseaseJacob C Trappenburg, Thierry Troosters, Martijn A Spruit, et al.
Respiratory Research|July 8, 2016
Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studiesFrançois Maltais, Anne-Marie Kirsten, Alan Hamilton, et al.
Respiratory Physiology & Neurobiology|October 3, 2012
Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patientsMarc Decramer, François Maltais, Gregory Feldman, et al.
Respiratory Medicine|May 3, 2011
Premature discontinuation during the UPLIFT studyMarc Decramer, Geert Molenberghs, Dacheng Liu, et al.
Respiratory Medicine|August 27, 2013
Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPDDonald P Tashkin, Ning Li, David Halpin, et al.
The New England Journal of Medicine|October 7, 2008
A 4-year trial of tiotropium in chronic obstructive pulmonary diseaseDonald P Tashkin, Bartolome Celli, Stephen Senn, et al.
Lung|June 17, 2011
Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trialDavid M G Halpin, Marc Decramer, Bartolome Celli, et al.
Respiratory Research|May 5, 2016
Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trialBartolomé R Celli, Marc Decramer, Dacheng Liu, et al.
Respiratory Research|January 12, 2011
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trialNicola A Hanania, Amir Sharafkhaneh, Bartolome Celli, et al.
Pageof 18